Array BioPharma News
Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference (Transcript)
Array BioPharma's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)
Get a head start on searching through ASCO abstracts with these 10 summaries.
BOULDER, Colo., May 15, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, MEK162 (licensed to Novartis) and selumetinib (licensed to AstraZeneca) ...
Five Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
This week, five Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare ConferencePR Newswire May 8
BOULDER, Colo., May 8, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare ...
Array BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcript